Renaissance Investment Management released its Q2 2025 investor letter, noting the stock market’s volatility and the S&P 500 hitting an all-time high in June. The Russell 1000 Growth returned 17.8%, and the S&P 500 returned 10.9% in the quarter, with large caps outperforming small caps. Thermo Fisher Scientific Inc.’s stock saw a one-month return of -0.11% and closed at $487.65 per share on September 9, 2025. The company lowered full-year guidance due to tariff-related macro weakness and NIH funding delays. Thermo Fisher Scientific Inc. is the 26th most popular stock among hedge funds, with revenue growing 3% to $10.85 billion in Q2 2025.

Read more at Yahoo Finance: Here’s What Dragged Thermo Fisher Scientific (TMO) in Q2